+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Vaccine Market - Global Forecast 2026-2032- Product Image
Canine Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Canine Vaccine Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142433
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Vaccine Market is projected to reach USD 2.30 Billion in 2026. It is expected to continue growing at a CAGR of 11.09%, reaching USD 4.35 Billion by 2032.

Canine Vaccines: Executive Overview

Canine vaccines support prevention of infectious diseases through routine immunization, risk-based protocols, and veterinary oversight. Demand is shaped by companion-animal ownership, pathogen exposure, regulatory requirements, access to veterinary services, and awareness of preventive care. Product selection commonly reflects the dog’s age, health status, lifestyle, geography, and exposure to other animals or wildlife.

Prevention Is Becoming More Risk-Based and Integrated

The landscape is shifting from uniform vaccination schedules toward individualized preventive-care plans. Veterinary professionals increasingly consider local disease prevalence, travel, boarding, shelter exposure, immunity history, and adverse-event risk when determining protocols. Improvements in cold-chain handling, electronic records, reminder systems, and diagnostic support are also strengthening continuity of care and reducing missed revaccination appointments.

Artificial Intelligence Strengthens Clinical and Operational Decisions

Artificial intelligence can support canine vaccination through appointment-risk identification, record reconciliation, clinical decision support, adverse-event signal detection, and demand planning. Its value depends on high-quality veterinary records, transparent validation, privacy safeguards, and professional oversight. AI should complement-not replace-licensed veterinary judgment, particularly where contraindications, coexisting disease, or uncertain immunization history are involved.

Regional Insights: Access, Regulation, and Disease Risk Differ

North America combines established companion-animal care infrastructure with strong emphasis on preventive protocols and digital reminders. Europe reflects varied national guidance, regulatory frameworks, and owner preferences across the European Union. Asia-Pacific includes highly diverse veterinary access conditions, urban growth, and cross-border movement patterns. Latin America faces uneven access and significant variation in household and community animal-care practices. The Middle East is influenced by import controls, travel, and expanding urban veterinary services, while Africa reflects substantial differences in veterinary capacity, vaccination access, and zoonotic-disease priorities between countries and communities.

Group Insights: Economic and Institutional Blocs Shape Coordination

ASEAN’s cross-border movement and varied veterinary infrastructures make harmonized guidance and reliable documentation important. BRICS countries encompass diverse regulatory systems, disease environments, and access conditions, requiring locally adapted delivery models. The European Union benefits from regional regulatory coordination while retaining national implementation differences. G7 members generally have mature veterinary systems and advanced recordkeeping, although access and adherence gaps remain. GCC countries are shaped by importation, travel, and urban pet-care demand. NATO members must account for differing national veterinary rules and mobility across allied jurisdictions.

Country Insights: National Context Determines Vaccination Practice

Australia emphasizes biosecurity and geographically varied disease-risk management. Brazil and Mexico require approaches suited to large and diverse animal-health systems. Canada and the United States combine broad veterinary access with variation by household income, geography, and local guidance. China, India, and Russia present substantial regional differences in access, regulation, and animal populations. France, Germany, Italy, Spain, and the United Kingdom operate within mature veterinary environments while reflecting distinct national policies and owner behavior. Japan and South Korea combine advanced urban veterinary services with strong interest in preventive pet care.

Action Priorities for Industry Leaders

Leaders should align products and education with evidence-based, risk-adjusted veterinary protocols; strengthen cold-chain and traceability systems; and design reminder tools that connect clinics, owners, and animal records. Partnerships with veterinary professionals, shelters, public-health agencies, and local distributors can improve access in underserved areas. Organizations should also invest in safety monitoring, transparent evidence communication, responsible AI governance, and localized education that addresses hesitancy without overstating benefits or minimizing limitations.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured review of the canine-vaccine landscape, emphasizing veterinary guidance, regulatory considerations, disease-prevention principles, care-delivery conditions, and geographic context. Findings are synthesized thematically across the specified regions, country groupings, and countries. The assessment excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis, and distinguishes documented structural factors from interpretive implications for industry decision-makers.

Conclusion: Build Trust, Access, and Adaptive Prevention

The canine-vaccine landscape is increasingly defined by individualized care, stronger documentation, evolving digital tools, and unequal access across geographies. Sustainable progress depends on clinically sound protocols, dependable distribution, responsible use of AI, transparent safety communication, and collaboration across veterinary and public-health stakeholders. Industry leaders that combine scientific rigor with locally appropriate delivery can help improve vaccination continuity and canine health outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Canine Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Conjugate
7.3. Inactivated
7.3.1. Monovalent
7.3.2. Multivalent
7.4. Live Attenuated
7.5. Recombinant
7.5.1. DNA-Based
7.5.2. Vector-Based
7.6. Subunit
7.6.1. Protein-Based
7.6.2. Toxoid
8. Canine Vaccine Market, by Disease Indication
8.1. Introduction
8.2. Core
8.2.1. Adenovirus
8.2.2. Distemper
8.2.3. Parainfluenza
8.2.4. Parvovirus
8.2.5. Rabies
8.3. Non-Core
8.3.1. Bordetella
8.3.2. Leptospirosis
8.3.3. Lyme
9. Canine Vaccine Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Subcutaneous
9.3. Intranasal
9.3.1. Drops
9.3.2. Spray
9.4. Oral
9.4.1. Liquid
9.4.2. Tablet
10. Canine Vaccine Market, by End User
10.1. Introduction
10.2. Animal Hospitals
10.2.1. General Hospitals
10.2.2. Specialty Hospitals
10.3. Pet Owners
10.4. Pharmacies
10.5. Veterinary Clinics
11. Canine Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Canine Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Canine Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Biogénesis Bagó S.A.
15.2. Boehringer Ingelheim International GmbH
15.3. Ceva Santé Animale S.A.
15.4. China Animal Husbandry Industry Co. Ltd.
15.5. Dechra Pharmaceuticals PLC
15.6. Elanco Animal Health Incorporated
15.7. Hester Biosciences Limited
15.8. HIPRA S.A.
15.9. IDEXX Laboratories Inc.
15.10. Indian Immunologicals Limited
15.11. Intas Pharmaceuticals Ltd.
15.12. Merck & Co. Inc.
15.13. Neogen Corporation
15.14. Phibro Animal Health Corporation
15.15. Vaxxinova GmbH
15.16. Vetoquinol S.A.
15.17. Virbac S.A.
15.18. Zoetis Inc.
15.19. Zydus Animal Health Limited
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Canine Vaccine Market, Years Considered for the Study
FIGURE 2. Global Canine Vaccine Market, Research Design
FIGURE 3. Global Canine Vaccine Market, Research Framework
FIGURE 4. Global Canine Vaccine Market, Data Triangulation
FIGURE 5. Global Canine Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Canine Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Canine Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Canine Vaccine Market Size, by Disease Indication, 2025 vs 2032 (%)
FIGURE 9. Global Canine Vaccine Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Canine Vaccine Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Canine Vaccine Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Canine Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Canine Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Canine Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Canine Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Canine Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Canine Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Canine Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Canine Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Canine Vaccine Market Segmentation & Coverage
TABLE 2. Global Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Conjugate Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Conjugate Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Conjugate Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Monovalent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Monovalent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Monovalent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Multivalent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Multivalent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Multivalent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Live Attenuated Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Live Attenuated Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Live Attenuated Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global DNA-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global DNA-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global DNA-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Vector-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Vector-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Vector-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Subunit Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Subunit Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Subunit Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Protein-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Protein-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Protein-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Toxoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Toxoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Toxoid Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 38. Global Core Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Core Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Core Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Adenovirus Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Adenovirus Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Adenovirus Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Distemper Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Distemper Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Distemper Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Parainfluenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Parainfluenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Parainfluenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Parvovirus Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Parvovirus Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Parvovirus Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Rabies Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Rabies Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Rabies Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Non-Core Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Non-Core Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Non-Core Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Bordetella Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Bordetella Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Bordetella Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Leptospirosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Leptospirosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Leptospirosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Lyme Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Lyme Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Lyme Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 69. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Intranasal Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Intranasal Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Intranasal Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Drops Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Drops Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Drops Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Spray Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Spray Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Spray Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Global Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global General Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global General Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global General Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Specialty Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Specialty Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Specialty Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Pet Owners Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Pet Owners Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Pet Owners Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 130. North America Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. North America Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 132. North America Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 133. North America Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 134. North America Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 135. North America Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 136. North America Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 137. North America Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 138. North America Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 139. North America Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 140. North America Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 141. North America Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 142. North America Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. North America Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 144. Latin America Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Latin America Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 146. Latin America Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 147. Latin America Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 148. Latin America Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 149. Latin America Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 150. Latin America Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 151. Latin America Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 152. Latin America Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 153. Latin America Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 154. Latin America Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 155. Latin America Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 156. Latin America Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Latin America Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 158. Europe Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Europe Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 160. Europe Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 161. Europe Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 162. Europe Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 163. Europe Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 164. Europe Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 165. Europe Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 166. Europe Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 167. Europe Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 168. Europe Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 169. Europe Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 170. Europe Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Europe Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 172. Middle East Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Middle East Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 174. Middle East Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 175. Middle East Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 176. Middle East Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 177. Middle East Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 178. Middle East Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 179. Middle East Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 180. Middle East Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 181. Middle East Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 182. Middle East Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 183. Middle East Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 184. Middle East Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Middle East Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 186. Africa Canine Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Africa Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 188. Africa Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 189. Africa Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 190. Africa Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 191. Africa Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 192. Africa Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 193. Africa Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 194. Africa Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 195. Africa Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 196. Africa Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 197. Africa Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 198. Africa Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Africa Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 200. Global Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. ASEAN Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. ASEAN Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 203. ASEAN Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 204. ASEAN Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 205. ASEAN Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 206. ASEAN Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 207. ASEAN Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 208. ASEAN Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 209. ASEAN Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 210. ASEAN Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 211. ASEAN Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 212. ASEAN Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 213. ASEAN Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. ASEAN Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 215. GCC Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. GCC Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 217. GCC Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 218. GCC Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 219. GCC Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 220. GCC Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 221. GCC Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 222. GCC Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 223. GCC Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 224. GCC Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 225. GCC Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 226. GCC Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 227. GCC Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. GCC Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 229. European Union Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. European Union Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 231. European Union Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 232. European Union Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 233. European Union Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 234. European Union Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 235. European Union Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 236. European Union Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 237. European Union Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 238. European Union Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 239. European Union Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 240. European Union Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 241. European Union Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. European Union Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 243. BRICS Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. BRICS Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 245. BRICS Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 246. BRICS Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 247. BRICS Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 248. BRICS Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 249. BRICS Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 250. BRICS Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 251. BRICS Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 252. BRICS Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 253. BRICS Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 254. BRICS Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 255. BRICS Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. BRICS Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 257. G7 Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. G7 Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 259. G7 Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 260. G7 Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 261. G7 Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 262. G7 Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 263. G7 Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 264. G7 Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 265. G7 Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 266. G7 Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 267. G7 Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 268. G7 Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 269. G7 Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. G7 Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 271. NATO Canine Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. NATO Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 273. NATO Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 274. NATO Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 275. NATO Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 276. NATO Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 277. NATO Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 278. NATO Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 279. NATO Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 280. NATO Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 281. NATO Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 282. NATO Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 283. NATO Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. NATO Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 285. Global Canine Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 286. United States Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 287. United States Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 288. United States Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 289. United States Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 290. United States Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 291. United States Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 292. United States Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 293. United States Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 294. United States Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 295. United States Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 296. United States Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 297. United States Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 298. United States Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. United States Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 300. Canada Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 301. Canada Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 302. Canada Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 303. Canada Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 304. Canada Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 305. Canada Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 306. Canada Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 307. Canada Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 308. Canada Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 309. Canada Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 310. Canada Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 311. Canada Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 312. Canada Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Canada Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 314. Mexico Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 315. Mexico Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 316. Mexico Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 317. Mexico Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 318. Mexico Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 319. Mexico Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 320. Mexico Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 321. Mexico Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 322. Mexico Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 323. Mexico Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 324. Mexico Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 325. Mexico Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 326. Mexico Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. Mexico Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 328. Brazil Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 329. Brazil Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 330. Brazil Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 331. Brazil Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 332. Brazil Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 333. Brazil Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 334. Brazil Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 335. Brazil Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 336. Brazil Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 337. Brazil Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 338. Brazil Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 339. Brazil Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 340. Brazil Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. Brazil Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 342. United Kingdom Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 343. United Kingdom Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 344. United Kingdom Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 345. United Kingdom Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 346. United Kingdom Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 347. United Kingdom Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 348. United Kingdom Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 349. United Kingdom Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 350. United Kingdom Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 351. United Kingdom Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 352. United Kingdom Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 353. United Kingdom Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 354. United Kingdom Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. United Kingdom Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 356. Germany Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 357. Germany Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 358. Germany Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 359. Germany Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 360. Germany Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 361. Germany Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 362. Germany Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 363. Germany Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 364. Germany Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 365. Germany Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 366. Germany Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 367. Germany Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 368. Germany Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 369. Germany Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 370. France Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 371. France Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 372. France Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 373. France Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 374. France Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 375. France Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 376. France Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 377. France Canine Vaccine Market Size, by Non-Core, 2017-2032 (USD Million)
TABLE 378. France Canine Vaccine Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 379. France Canine Vaccine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 380. France Canine Vaccine Market Size, by Intranasal, 2017-2032 (USD Million)
TABLE 381. France Canine Vaccine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 382. France Canine Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 383. France Canine Vaccine Market Size, by Animal Hospitals, 2017-2032 (USD Million)
TABLE 384. Russia Canine Vaccine Market Size, 2017-2032 (USD Million)
TABLE 385. Russia Canine Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 386. Russia Canine Vaccine Market Size, by Inactivated, 2017-2032 (USD Million)
TABLE 387. Russia Canine Vaccine Market Size, by Recombinant, 2017-2032 (USD Million)
TABLE 388. Russia Canine Vaccine Market Size, by Subunit, 2017-2032 (USD Million)
TABLE 389. Russia Canine Vaccine Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 390. Russia Canine Vaccine Market Size, by Core, 2017-2032 (USD Million)
TABLE 391. Russia C

Companies Mentioned

  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • China Animal Husbandry Industry Co. Ltd.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA S.A.
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Merck & Co. Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vaxxinova GmbH
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.
  • Zydus Animal Health Limited

Related Topics

Related Reports

Canine Vaccine Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Valence Type, Administration Route, Indication - Product Image

Canine Vaccine Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Valence Type, Administration Route, Indication

  • Report
  • 160 Pages
  • Global
From
Dog Vaccine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Dog Vaccine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 142 Pages
  • Global
From
Dog Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Disease Type, Route of Administration, Distribution Channel - Product Image

Dog Vaccines Market Outlook 2026-2034: Market Share, and Growth Analysis by Vaccine Type, Disease Type, Route of Administration, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Dog Vaccines Market Report 2026 - Product Image

Dog Vaccines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Canine influenza Vaccines Market - Global Strategic Business Report - Product Image

Canine influenza Vaccines Market - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.